Karyopharm Therapeutics (KPTI) Commences 2.2M Common Stock Offering
Tweet Send to a Friend
Karyopharm Therapeutics (NASDAQ: KPTI) announced that it has commenced an underwritten public offering of 2,200,000 shares of its common stock ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE